U.S. Tobacco Stock News

NasdaqCM:HFFG
NasdaqCM:HFFGConsumer Retailing

HF Foods Group (HFFG) Earnings Slip Back To Loss Challenges Profitability Turnaround Narrative

HF Foods Group (HFFG) has just posted its FY 2025 third quarter numbers, with revenue at US$307 million and a basic EPS loss of US$0.02, while on a trailing 12 month basis revenue sits at about US$1.23 billion and basic EPS at a loss of US$0.86. The company has seen quarterly revenue move from US$302 million in Q2 FY 2024 to US$307 million in Q3 FY 2025, with basic EPS shifting across that period from roughly breakeven at US$0.00 in Q2 FY 2024 to a loss of US$0.02 in the latest quarter...
NasdaqGS:TRST
NasdaqGS:TRSTBanks

TrustCo Bank Corp NY (TRST) Net Margin Improvement Reinforces Bullish Narratives

TrustCo Bank Corp NY (TRST) has rounded out FY 2025 with fourth quarter revenue of US$47.8 million and basic EPS of US$0.85, backed by trailing twelve month revenue of US$186.3 million and EPS of US$3.26. Over the past year, revenue has moved from US$169.8 million to US$186.3 million on a trailing basis, while basic EPS has shifted from US$2.57 to US$3.26. This sets the scene for investors to focus on how net profit margins at 32.8% and recent earnings growth shape the quality of this...
NYSE:HUYA
NYSE:HUYAEntertainment

Huya (NYSE:HUYA) Swings Back To Q3 EPS Profit Challenging Ongoing Loss Concerns

HUYA (NYSE:HUYA) has posted its latest FY 2025 numbers with Q3 revenue of C¥1.7b and basic EPS of C¥0.04, giving investors an opportunity to reassess the streaming platform's earnings path. The company reported revenue of C¥1.5b in Q1 2025, C¥1.6b in Q2 2025, and C¥1.7b in Q3 2025, while basic EPS moved from C¥0.00 in Q1 to a loss of C¥0.02 in Q2 before returning to a profit of C¥0.04 in Q3. This presents a mixed picture on margins but offers a clearer view of where profitability pressure...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Microvast Holdings (MVST) Breakeven EPS In Q3 2025 Tests Profitability Narratives

Microvast Holdings (MVST) has posted its latest FY 2025 numbers with Q3 revenue at US$123.3 million, basic EPS at a loss of US$0.00 per share, and net income at a loss of US$1.5 million, while the trailing twelve months show revenue of US$444.5 million and a loss per share of US$0.40. The company has seen quarterly revenue range from US$83.7 million to US$123.3 million over the last six reported periods. Over the same period, basic EPS has swung between a profit of US$0.19 and losses of up to...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Is It Too Late To Consider Golar LNG (GLNG) After Its Strong Multi Year Share Price Run?

Investors wondering if Golar LNG is still reasonably priced after a strong run, or if the easy gains are already behind it, can use this article to focus on what the current share price indicates about value. The stock recently closed at US$44.86, with returns of 3.3% over 30 days, 18.2% year to date and 31.0% over the last year. The past 3 years and 5 years show very large gains of 142.3% and 326.6% respectively. Recent coverage has centered on how Golar LNG is positioned within the energy...
NYSE:HHH
NYSE:HHHReal Estate

Do Diverging Moves Around Earnings Reveal a Turning Point in Howard Hughes' (HHH) Governance Story?

Recent filings show Concorde Financial Corp fully exited its position in Howard Hughes Holdings by selling 52,047 shares, while General Counsel Joseph Valane bought 1,260 shares shortly after the company posted fourth-quarter 2025 results with lower-than-expected EPS but higher-than-expected revenue of US$624.4 million. These opposing moves by an institutional investor and a senior insider come as Howard Hughes pursues a holding-company pivot, faces leverage concerns, and attracts growing...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

A Look At BioMarin Pharmaceutical (BMRN) Valuation After A Year Of Softer Share Price Momentum

BioMarin Pharmaceutical (BMRN) is back on investor watch after recent trading left the shares about 20% lower over the past year, despite annual revenue of US$3.2b and net income of US$348.9m. See our latest analysis for BioMarin Pharmaceutical. The recent 1 day share price return of 1.85% decline and 7 day share price return of 5.67% decline sit against a 90 day share price return of 10.93% and a 1 year total shareholder return of 19.73% decline, suggesting short term momentum has softened...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

What Strategic Education (STRA)'s Analyst Upgrades and Earnings Revisions Mean For Shareholders

In recent weeks, analysts have raised their earnings forecasts for Strategic Education and upgraded the stock to a Zacks Rank #1 (Strong Buy), signaling higher confidence in its expected financial performance. This broad-based improvement in earnings estimates suggests that analysts are reassessing the company’s underlying business trends rather than reacting to a single, one-off development. We’ll now examine how this stronger analyst earnings outlook may reshape Strategic Education’s...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

EyePoint (EYPT) Is Down 14.2% After Weak Q4 Results And DURAVYU Optimism - What's Changed

EyePoint Pharmaceuticals reported fourth-quarter 2025 revenue of US$620,000 versus US$11.59 million a year earlier, with net loss widening to US$67.61 million and basic loss per share from continuing operations rising to US$0.81, while also granting long-term stock options and ending 2025 with cash reportedly sufficient to fund operations into late 2027. Despite weaker financial results, investor attention has shifted toward the CEO’s recent purchase of 1,500 shares, analyst optimism linked...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

Is It Time To Reassess QCR Holdings (QCRH) After Recent Share Price Weakness?

Wondering if QCR Holdings at around US$82.64 is offering value or asking too much at today's price? This breakdown will help you see what the current market is really pricing in. The stock has seen a 0.9% decline over the last 7 days and a 10.5% decline over the last 30 days, while returns sit at 0.6% year to date and 11.6% over the past year. This gives you a mixed set of signals to weigh. Recent news coverage has focused on QCR Holdings as a regional banking name that investors continue to...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Payoneer ESOP Shelf Filing Raises Fresh Questions On Dilution And Growth

Payoneer Global (NasdaqGM:PAYO) has filed a shelf registration statement for a potential US$79 million offering tied to its Employee Stock Ownership Plan. The filing sets up the ability to issue or sell shares in connection with the ESOP over time, affecting how employee equity is managed. This move adds a fresh element to the Payoneer equity story beyond the recent focus on partnerships and valuation discussion. Payoneer operates a global payments and financial services platform that...
NYSE:GNL
NYSE:GNLREITs

Balance Sheet Deleveraging And Cost Controls Might Change The Case For Investing In Global Net Lease (GNL)

In recent meetings with Global Net Lease’s leadership, Citizens analyst Mitch Germain reaffirmed his view on the company after management outlined progress in cutting leverage from 8.5x at its peak to 6.7x by year-end 2025 through approximately US$3.40 billion of asset sales, alongside an updated capital allocation plan. The company also reported past fourth-quarter 2025 earnings per share of US$0.16, beating analyst expectations despite revenue falling short, indicating that cost controls...
NYSE:SR
NYSE:SRGas Utilities

Is Spire (SR) Still Attractive After Recent Share Price Gains?

Wondering if Spire's current share price still offers value, or if most of the opportunity is already priced in? This article breaks down what the numbers can and cannot tell you about that question. Spire recently closed at US$92.11, with returns of 0.3% over the past week and month, 10.7% year to date, and 25.7% over the last year, alongside 49.7% over three years and 57.5% over five years. Recent coverage around Spire has focused on its position within the gas utilities space and how...
NasdaqGS:CTMX
NasdaqGS:CTMXBiotechs

A Look At CytomX Therapeutics (CTMX) Valuation After Varseta M Phase 1 Expansion Data And Earnings Update

CytomX Therapeutics earnings and Varseta-M data come into focus CytomX Therapeutics (CTMX) is back on radar after reporting full year 2025 results alongside early Phase 1 expansion data for its EpCAM-targeting ADC, Varseta-M, in late-line metastatic colorectal cancer. See our latest analysis for CytomX Therapeutics. The recent Varseta-M data, full year 2025 results and a new shelf registration plus follow-on equity filing have coincided with sharp share price momentum, with a 1 day share...
NYSE:VFC
NYSE:VFCLuxury

Is V.F (VFC) Signaling Deeper Structural Strains With Its Latest Investor Conference Update?

Earlier this month, V.F. Corporation presented at Citi’s 2026 Global Consumer & Retail Conference in Aventura, Florida, outlining its latest business updates to investors and industry participants. The event comes amid scrutiny of VF Corp’s shrinking constant-currency revenue, pressured free cash flow margins, and declining return on invested capital, which together highlight ongoing operational headwinds. Next, we’ll examine how these signs of weakening demand and lower returns on invested...
NYSE:IRM
NYSE:IRMSpecialized REITs

Iron Mountain Expansion And Dividend Raise Reshape Its Growth Story

Iron Mountain (NYSE:IRM) has agreed to acquire ACT Logistics in Australia as part of its global expansion. The company continues to grow its data center segment, adding to its traditional records management operations. Iron Mountain recently raised its dividend by 10%, highlighting its focus on shareholder returns. Iron Mountain, best known for records storage and information management, is in the middle of a meaningful shift in where its business is growing. The ACT Logistics deal broadens...
NYSE:IVZ
NYSE:IVZCapital Markets

Invesco Ties Trump Accounts Benefit To Long Term Savings Story

Invesco, NYSE:IVZ, has introduced an employee benefit that supports new U.S. government "Trump Accounts" under Section 530A child savings accounts. The company plans to match the initial government contribution for eligible children of its employees, adding a private employer layer to the federal program. This move links Invesco's employee benefits directly to a current policy initiative focused on long term child savings. For investors tracking NYSE:IVZ, this new benefit sits alongside a...
NYSE:CALY
NYSE:CALYLeisure

Is It Too Late To Reassess Callaway Golf (CALY) After A 108% One Year Rally?

If you are wondering whether Callaway Golf at around US$13.25 is still good value after a strong run, the key is understanding what the current price actually reflects. The stock has returned 13.1% year to date, including a 5.2% gain over the last 30 days. The 1 year return of 108.0% contrasts with a 36.8% decline over 3 years and a 53.6% decline over 5 years. Recent headlines have focused on how the share price recovery compares with its longer term track record and what that means for...
NYSE:FLG
NYSE:FLGBanks

Is Flagstar Bank (FLG) Fairly Priced After Recent 12% One Month Share Price Slide?

If you are wondering whether Flagstar Bank National Association's current share price reflects its true worth, this breakdown will help you make sense of what you are paying for. The stock last closed at US$12.45, with returns of 4.2% over the past year, but a 12.2% decline over the last 30 days and a 48.4% decline across three years. Recent coverage has focused on Flagstar Bank National Association as part of the wider US regional banking sector, with attention on how individual banks are...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

US Stock Market Today: S&P 500 Futures Edge Higher On Mixed Factory Data And Yields

The Morning Bull - US Market Morning Update Tuesday, Mar, 17 2026 E-mini S&P 500 futures are pointing higher this morning, up about 0.4%, as investors juggle mixed US factory data and rising pressure from the bond market. The NY Empire State Manufacturing Index sits at -0.2 in March, which means activity in New York factories has essentially stalled, a concern for jobs and overtime pay in industrial regions. At the same time, the 10 year US Treasury yield is holding near 4.24%, keeping...
NasdaqGM:NVTS
NasdaqGM:NVTSSemiconductor

Navitas Targets AI Racks With New 800 V GaNFast Power Architecture

Navitas Semiconductor unveiled a GaNFast powered 800 V to 6 V DC-DC power delivery board for AI data centers. The new architecture removes the traditional 48 V intermediate bus and is tailored for advanced NVIDIA AI infrastructure. The solution is being showcased at NVIDIA GTC 2026 and APEC 2026, highlighting real world validation with major industry partners. For investors watching NasdaqGM:NVTS, this announcement comes with the stock at $10.49, alongside a 25.2% return over the past week...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

Assessing CorMedix (CRMD) Valuation After Recent Share Price Weakness And Long Term Gains

Stock performance context for CorMedix Without a specific news catalyst driving fresh headlines, CorMedix (CRMD) continues to draw attention as investors weigh its recent share performance in relation to its role in developing therapies for life threatening conditions. The stock last closed at US$6.54, with returns showing mixed momentum. It recorded a 1.4% gain over the past day, alongside a slight decline over the past week. See our latest analysis for CorMedix. Recent trading tells a mixed...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

Did Silicon Labs’ In‑Tire Sensor Deal With BANF Just Shift Silicon Laboratories’ (SLAB) Investment Narrative?

Earlier this month, BANF announced a collaboration with Silicon Labs to integrate the ultra‑low‑power BG22 Bluetooth LE SoC and Secure Vault security into BANF’s new in‑tire, battery‑free sensor platform for autonomous and connected vehicles. By digitizing real‑time tire conditions with on‑tire data processing and wireless power transfer, the partnership turns tires into high‑value data sources for safety, fleet management, and future predictive services. We’ll now examine how embedding...
NasdaqGS:SVCO
NasdaqGS:SVCOSoftware

A Look At Silvaco Group (SVCO) Valuation After Earnings Beat And AI Segment Growth

Silvaco Group (SVCO) surprised the market with quarterly results that came in ahead of expectations, along with revenue guidance above earlier forecasts and cost cuts tracking better than management initially outlined. See our latest analysis for Silvaco Group. Silvaco Group’s recent earnings beat and upbeat guidance have been met with sharp share price momentum, with a 7 day share price return of 53.5% and a year to date share price return of 22%, even though the 1 year total shareholder...